This is the final part of our ADA series, covering updates on Type 1 and Type 2 diabetes research from the American Diabetes Association’s 77th Scientific Sessions. Well done if you’ve stuck with us, we hope you’ll enjoy this final part on looking after our hearts and minds. Hearts and minds In 2007, we didn’t…

If you caught our Type 1 diabetes research highlights from the American Diabetes Association’s 77th Scientific Sessions – the largest diabetes conference in the world – last week, we’re back now with our Type 2 series. This is part one of two, with research updates on gut bacteria, the beta cell, and the latest treatment…

Although, I’m not quite 18 years old and have literally only been diagnosed with Type 1 diabetes for less than a year, I am told to remain optimistic – what’s a lifelong condition anyway? As everyone keeps telling me, “It could be worse?” Of course, it’s easier for ‘them’ to say, after all, they’re not…

In a regular blog series, Simon O’Neill, Diabetes UK’s Director of Health Intelligence and Professional Liaison, rounds up the latest diabetes news. This week Simon updates on new technologies, medicines and treatments. Verily (Google) Smart Lenses Back in 2014, I wrote about Google’s contact lens blood glucose monitoring solution and explained that this wasn’t a…

I very consciously avoid being defined by diabetes. There is little in my life that is done because of diabetes apart from what I do to stay alive. As a consequence I don’t spend much time with other people with diabetes. I’m not comfortable with the idea of a support group who I meet up with…

This is the final part of our Type 1 ADA series (congrats if you’ve stuck with us!), and we’re covering complications – from controversial foot ulcer treatments to the REMOVAL trial. Hyperbaric oxygen therapy:  fact or fiction? Hyperbaric oxygen therapy (HBOT) was developed in the 1930s as a treatment for decompression sickness. It involves sitting…